Charla-jo Olorenshaw Spradlin, PT | |
26453 N Old Highway 95, Athol, ID 83801-7076 | |
(208) 597-4595 | |
Not Available |
Full Name | Charla-jo Olorenshaw Spradlin |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 26453 N Old Highway 95, Athol, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720390347 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT-425 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Charla-jo Olorenshaw Spradlin, PT 26453 N Old Highway 95, Athol, ID 83801-7076 Ph: (208) 597-4595 | Charla-jo Olorenshaw Spradlin, PT 26453 N Old Highway 95, Athol, ID 83801-7076 Ph: (208) 597-4595 |
News Archive
An experiment carried out on rodents exposed to fuel similar to that of the Prestige tanker oil spill - which took place nearly a decade ago - shows that inhalation of the fuel causes damage to genetic material. According to the study, led by the University of A Coru-a, the results could be used in relation to people who carry out the industrial cleaning of coasts.
Although the world is focused on the COVID-19 pandemic, there are many other dangerous pathogens still out there, like Yersinia pestis, which causes plague – the deadly disease that killed tens of millions of people during the infamous Black Death in the 14th century.
Health technology company Infonaut, a MaRS client, has released a study showing that hospital patients may be at significant risk of infection due to their own poor hand hygiene.
Women who have had pre-cancerous cells removed remain at higher than average risk of developing cervical cancer in the 20 years following treatment, says research in the British Medical Journal (BMJ).
Guided Therapeutics, Inc., developer of a rapid and painless biophotonic testing platform for the early detection of cancer, today announced that, after a series of meetings with the U.S. Food and Drug Administration (FDA), and after reviewing draft responses, the FDA has asked the company to provide additional information in the company's response to one remaining question.
› Verified 5 days ago